![]() Organic constant currency 1 revenue performance in Asia Pacific was negative, reflecting declines in China, partially offset by a strong performance in Australasia. ![]() The Environmental & Analysis sector's first half Return on Sales 2 is expected to be lower due to mix effects.īy geography, the USA and Mainland Europe have delivered strong organic constant currency 1 revenue growth, while the UK has grown modestly together, these account for nearly 80% of Group revenue. Return on Sales 2 in the Safety and Healthcare sectors is expected to be higher in the first half of the year, relative to the comparable period last year. All sectors will benefit from recent acquisitions. Revenue by sector on an organic constant currency 1 basis reflects order book trends, with stronger growth in the Safety and Environmental & Analysis sectors, and similar revenue to the first half of last year in the Healthcare sector. Order intake in the Safety and Environmental & Analysis sectors is in line with revenue the Healthcare sector has experienced slower order intake, with the effects of recovery from post-COVID disruptions resulting in destocking by OEM customers and budgetary pressures at healthcare providers. Group order intake is ahead of the comparable period last year and close to revenue in the year to date. These are enabling us to deliver continued progress in varied market conditions. We continue to benefit from the strength and relevance of our purpose, the agility and entrepreneurialism which we derive from our Sustainable Growth Model, and the diversity and global reach of our portfolio. Our cash performance is enabling continued investment, both organically and in acquisitions, to expand our opportunities for growth over the medium to longer term.Ĭontinued progress in varied market conditions We expect the balance of revenue and Adjusted profit before taxation 4 between the first and second half of this financial year to be in line with pre-COVID historical averages 5.Īccordingly, in the first half of the year, we expect good organic constant currency 1 revenue growth against a strong comparative period last year, and Return on Sales 2 towards the lower end of our target range. Our guidance for the full year to March 2024, for good organic constant currency 1 revenue growth and Return on Sales 2 of approximately 20%, is unchanged from that given in our results announcement in June 3. We have made further progress in the first half of this financial year despite varied market conditions. Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future, today releases its scheduled trading update ahead of its half year end on 30 September 2023.įurther progress in the first half and unchanged guidance for the full year
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |